Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01747928 · ClinicalTrials.gov registry record · Early Phase 1
Users Study Of The Caverject Delivery System
A Early Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
NCT01747928: Completed Early Phase 1 study, sponsored by Pfizer.
NCT01747928 is a Early Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 48 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01747928, a Early Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
Usability testing of the dual-chambered syringe in conjunction with the proposed patient instructions for use.
Primary Outcome
DSSR was defined as percentage of participants who were able to successfully expel the selected dose from the Caverject Impulse Dual Chamber Delivery System when relying on the modified Instructions for Use (IFU). The process was considered successful if the attempt was observed and documented by study personnel AND the participant didn't receive any operational/"hands on" demonstration on how to operate the plunger from study personnel AND after performing all preparatory steps, the participant
Interventions
- OTHER dual-chamber syringe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
What the finished NCT01747928 record still lists
NCT01747928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which dual-chamber syringe is the first listed.
NCT01747928 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01747928 about?
NCT01747928 is a clinical study titled "Users Study Of The Caverject Delivery System". Usability testing of the dual-chambered syringe in conjunction with the proposed patient instructions for use.
What is the current status of trial NCT01747928?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2013-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01747928?
The interventions under investigation include: dual-chamber syringe (OTHER).
Who is sponsoring clinical trial NCT01747928?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01747928's enrollment target sits among peer trials
48 541st of 2000 higher than 1,439 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia